Triangular warning icon with an exclamation mark.
Winter Weather Shipping Delays Contact us

Due to inclement weather conditions there may be delays in our shipping services. Please note that your order could be impacted by these expected weather-related disruptions. Thank you for your understanding and support!

American Type Culture Collection (ATCC) Logo American Type Culture Collection (ATCC) Logo Cart 0
  • Quick Order
  • Careers
  • Support
Colony of bacteria close-up 3D rendering illustration on blue background

Innovating Microbial QC: How MicroQuant Transforms Speed, Accuracy, and Resource Efficiencies

January 29, 2026, at 12:00 PM ET

Microbial quality control is undergoing a transformation, and ATCC’s MicroQuant™ is at the forefront. This webinar will showcase how MicroQuant’s ready-to-use, quantitated microbial controls help QC labs streamline workflows, reduce variability, and achieve pharmacopeial compliance with confidence.

What You’ll Learn:

  • Precision & Compliance: How MicroQuantTM ensures reproducible results across USP chapters <51>, <60>, <61>, <62>, <71>, <72>, and <1072>.
  • Efficiency Gains: Why single-use, refrigerator-stable pellets reduces hands-on time, minimize errors, and lower operational costs compared to frozen stocks.
  • Performance Insights: Real-world data from ATCC studies and the new white paper “The MicroQuantTM Advantage” demonstrating improved outcomes in pharmacopeial QC methods.
  • Authenticated Materials: Why using authenticated microbial reference materials is critical for QC—ensuring scientific integrity, traceability, and regulatory confidence while reducing risk of contamination or variability.
Join us to discover how innovation in microbial QC can empower your lab to achieve more—faster, smarter, and with greater confidence.

Watch the webinar

Presenter

Nilay Chakraborty.jpg

Nilay Chakraborty, PhD, MBA

Principal Scientist, BioNexus, ATCC

Dr. Nilay Chakraborty is the BioNexus Foundation Principal Scientist at ATCC. He is an expert in the area of biopreservation and currently focuses on strategic development of innovative products at ATCC. An engineer by training, Nilay received his MBA from Indian Institute of Engineering Science and Technology and PhD from University of North Carolina. He developed several innovative technologies on biopreservation and cell-based technologies during his tenure at the Center for Engineering in Medicine in Harvard Medical School, Massachusetts General Hospital and Shriners Burns Hospital. Prior to joining ATCC, Nilay was a tenured Associate Professor at University of Michigan, Dearborn, and served as the Provost Fellow and Chair of the Research Committee for College of Engineering at University of Michigan. He has designed and developed several programs at the University of Michigan that focused on success of first-generation college students. Nilay served as a PI of several Federal Research Grants and served as a reviewer for Federal Scientific bodies including NSF and NIH. He has multiple patents and has actively worked in the area technology translation area by creating two successful startup businesses. At ATCC, Dr. Chakraborty is developing a core group centered around advancing ATCC’s core competencies in preservation sciences and strategic development of innovative biological products that leverages recent advances in preservation technology and bioengineering.